РЕКОНСТРУКТИВНО-ПЛАСТИЧЕСКИЕ ОПЕРАЦИИ У БОЛЬНЫХ С BRCA1-АССОЦИИРОВАННЫМ РАКОМ МОЛОЧНОЙ ЖЕЛЕЗЫ

рак молочной железы, реконструктивно-пластическая операция

1. Khansa I., Wang D., Coriddi M.,Tiwari P. et al. Timing of prophylactic hysterectomy-oophorectomy, mastectomy, and microsuargical breast reconstruction in BRCA1 and BRCA2 carriers // Microsurgery. 2013. Vol. 7. № 10. P. 1002.

2. Lizarraga I. M., Sugg S. L., Weigel R. J., Scott-Conner C.E // Am. J. Surg. 2013. Vol. 206. № 5. P. 704-708.

3. Matloff E. T., Bonadies D. C., Moyer A., Brierley K. L. Changes in specialists’ perspectives on cancer genetic. Testing, prophylactic surgery and insurance discrimination: then and now // J. Genet. Couns. 2013. Vol. 13. P. 142-144.

4. Nippert I., Julian-Reynier C., Harris H. et al. Cancer risk communication, predictive testing and management in France, Germany, the Netherlands and the UK: general practitioners and breast surgeons current practice and preferred practice responsibilities // J. Community Genet. 2014. Vol. 5. № 1. P. 9-79.

5. Pan H., He Z., Ling L. Reproductive factors and breast cancer risk among BRCA1 or BRCA2 mutation carriers: results from ten studies // Cancer Epidemiol. 2013. Vol. 11. P. 121-128.

6. Peled A. W., Irwin C. S., Hwang E. S. et al. Total skin-sparing mastectomy in BRCA mutation carriers // Ann. Surg. Oncol. 2014. Vol. 21. № 1. P. 37-41.